As a National Cancer Institute (NCI)–designated comprehensive cancer center, the OSUCCC – James offers patients access to novel therapies that may not be available anywhere else in the United States. The OSUCCC – James leads some of the world’s most advanced, sophisticated clinical trials for blood disorders.
The nationally and internationally renowned subspecialists at the OSUCCC – James understand that blood disorders like sickle cell anemia are highly complex.
Because of that understanding, the most effective means of treating patients with blood disorders comes from an expert team approach from across multiple medical disciplines. These teams run groundbreaking studies and through detailed observations, evaluate the latest treatments and targeted therapies. In fact, the OSUCCC – James is a national leader in a new study of drugs to prevent sickle cell crisis as well as research in developing essential reactions to red blood cells.
Our team of experts analyzes the genetic composition of each individual’s type of blood disorder to determine the best possible treatment, offering improved outcomes, faster responses and fewer side effects.
If you’ve been diagnosed with sickle cell anemia, would like a second opinion or would like to speak with a blood disorder specialist, please call The James Line at 800-293-5066 or 614-293-5066 to make an appointment.
Treatment
The internationally recognized experts at the OSUCCC – James believe the best way to treat patients and manage their disease successfully is to be at the forefront of delivering the latest, most effective treatments available and by working with nationally and internationally renowned experts to develop the newest sickle cell anemia treatments and programs.
Sickle cell anemia treatments work to relieve symptoms and to treat any complications that may arise. This can include blood-transfusion treatment to provide a new source of functional hemoglobin as well as treatments to prevent infections, organ damage and strokes.
In some cases, a blood and marrow stem cell transplant may even offer a cure for some sickle cell anemia patients.
If you’ve been diagnosed with sickle cell anemia, would like a second opinion, would like more information on available clinical trials, or would like to speak with a blood disorder specialist, please call The James Line at 800-293-5066 or 614-293-5066 to make an appointment.
(Source: National Institutes of Health)
Sickle Cell Anemia Research and Clinical Trials
For blood disorder patients, clinical trials mean hope. The OSUCCC – James has more than 500 open clinical trials at any given time, with some of the world’s latest discoveries available to clinical trial patients right here in Columbus, Ohio. In fact, patients have access to more of this nation’s leading-edge, targeted treatments and drugs than at most hospitals in America.
One recent breakthrough was an international study led by OSUCCC – James researchers that evaluated a small pill patients would take once daily and that replaced painful, eight- to 12-hour injection treatments for iron overload – a debilitating complication that arises from multiple blood transfusions. The study was successful and is now an accepted treatment for sickle cell patients.
In addition, OSUCCC – James researchers are currently working with other sickle cell institutions and major pharmaceutical companies to evaluate new treatments. This includes one study that may inhibit sickle red blood cells from attaching to the blood vessel walls and blocking blood flow to organs. The OSUCCC – James is one of the major sites for the study.
If you’ve been diagnosed with sickle cell anemia, would like a second opinion or would like to speak with a blood disorder specialist, please call The James Line at 800-293-5066 or 614-293-5066 to make an appointment.
Who Should Participate in a Clinical Trials
For blood disorder patients, clinical trials mean hope. Patients can enter clinical trials before, during or after starting their individual treatments.
The OSUCCC – James is one of only a few U.S. cancer centers funded by the National Cancer Institute to conduct phase I and phase II clinical trials on novel anticancer drugs. These trials go only to centers that demonstrate an exemplary capacity for research and clinical care, the expertise to deliver the latest in treatments, and the infrastructure to interpret and track treatment results.
If you’ve been diagnosed with sickle cell anemia or another blood disorder, would like a second opinion, would like more information on available clinical trials or would like to speak with a blood disorder specialist, please call The James Line at 800-293-5066 or 614-293-5066 to make an appointment.